Skip to main content

Advertisement

Log in

Lipoprotein glomerulopathy with membranoproliferative pattern in a patient with cholestatic liver disease—lesson for the clinical nephrologist

  • Lessons for the Clinical Nephrologist
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Data availability

The dataset used in the case report will be available from the corresponding author on a reasonable request.

References:

  1. Saito T, Sato H, Kudo K, Oikawa S, Shibata T, Hara Y, Yoshinaga K, Sakaguchi H (1989) Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis 13(2):148

    Article  CAS  PubMed  Google Scholar 

  2. Cambruzzi E, Pêgas KL (2019) Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review. J Bras Nefrol 41(3):393–399

    Article  PubMed  Google Scholar 

  3. Kollbrunner L, Hirt-Minkowski P, Sanz J, Bresin E, Neuhaus TJ, Hopfer H, Jehle AW (2021) Case report: lipoprotein glomerulopathy complicated by atypical hemolytic uremic syndrome. Front Med 8:679048

    Article  Google Scholar 

  4. Vaziri ND (2016) Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 90(1):41

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Vaziri ND, Liang K (2002) Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome. Kidney Int 61(5):1769

    Article  CAS  PubMed  Google Scholar 

  6. Vaziri ND, Liang KH (1995) Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis. Kidney Int 48(6):1979

    Article  CAS  PubMed  Google Scholar 

  7. Sato T, Liang K, Vaziri ND (2002) Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis. Kidney Int 61(1):157

    Article  CAS  PubMed  Google Scholar 

  8. Liu S, Vaziri ND (2014) Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome. Nephrol Dial Transplant 29(3):538

    Article  CAS  PubMed  Google Scholar 

  9. Fornoni A, Radhakrishnan J (2022) Lipid abnormalities in nephrotic syndrome. In: UpToDate. Accessed 11 Sep 2022.

Download references

Acknowledgements

None.

Funding

None recieved.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Avinash Rao Ullur.

Ethics declarations

Conflict of interest

None.

Ethical approval

Not applicable.

Statement of human and animal rights

Not applicable.

Informed consent

Recieved.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 30 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rao Ullur, A., Avila-Casado, C., Agrawal, V. et al. Lipoprotein glomerulopathy with membranoproliferative pattern in a patient with cholestatic liver disease—lesson for the clinical nephrologist. J Nephrol 36, 2391–2394 (2023). https://doi.org/10.1007/s40620-023-01653-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-023-01653-5

Keywords

Navigation